Upgrade to SI Premium - Free Trial

Canaccord Reiterates Buy Rating on Guardant Health (GH)

April 7, 2026 6:25 AM
Canaccord analyst Kyle Mikson reiterated a Buy rating and $135.00 price target on Guardant Health (NASDAQ: GH).The analyst commented: "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments